Literature DB >> 1649343

Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 tat transactivator protein.

P J Dillon1, J Lenz, C A Rosen.   

Abstract

A replication-competent Akv murine leukemia virus-based vector encoding the human immunodeficiency virus tat cDNA under control of the simian virus 40 early promoter sequences was constructed. The simian virus 40 tat sequences were placed within the U3 region of the 3' long terminal repeat. The resulting virus, derived by transfection, replicated efficiently in mouse NIH 3T3 cells and maintained the tat cDNA insert. It has been suggested that Tat function requires the presence of a human-specific cofactor, which is absent in murine cells. However, infection of murine cells with the Akv virus encoding tat resulted in significant transactivation of a human immunodeficiency virus long terminal repeat-driven reporter gene, indicating that human cofactors are not always required for Tat function. The vector system described may be useful for introduction of foreign genes in vivo and in whole animals when virus spread is required for efficient infection and levels of gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649343      PMCID: PMC248891     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

2.  Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

Authors:  J Sodroski; R Patarca; C Rosen; F Wong-Staal; W Haseltine
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

6.  The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.

Authors:  J Vogel; S H Hinrichs; R K Reynolds; P A Luciw; G Jay
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

7.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.

Authors:  B Ensoli; G Barillari; S Z Salahuddin; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1990-05-03       Impact factor: 49.962

8.  Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

Authors:  R P Viscidi; K Mayur; H M Lederman; A D Frankel
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

9.  Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance.

Authors:  H Stuhlmann; R Jaenisch; R C Mulligan
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

10.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

Authors:  S K Arya; C Guo; S F Josephs; F Wong-Staal
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

View more
  7 in total

1.  Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.

Authors:  C R Logg; A Logg; C K Tai; P M Cannon; N Kasahara
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A.

Authors:  Z Chang; J Pan; C Logg; N Kasahara; P Roy-Burman
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors.

Authors:  C R Logg; C K Tai; A Logg; W F Anderson; N Kasahara
Journal:  Hum Gene Ther       Date:  2001-05-20       Impact factor: 5.695

4.  Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.

Authors:  Matthias Paar; Sonja Schwab; Doris Rosenfellner; Brian Salmons; Walter H Günzburg; Matthias Renner; Daniel Portsmouth
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

5.  Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice.

Authors:  H J Brady; D J Abraham; D J Pennington; C G Miles; S Jenkins; E A Dzierzak
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  Design and synthesis of a quintessential self-transmissible IncX1 plasmid, pX1.0.

Authors:  Lars H Hansen; Mikkel Bentzon-Tilia; Sara Bentzon-Tilia; Anders Norman; Louise Rafty; Søren J Sørensen
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

7.  Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector.

Authors:  Karol M Budzik; Rebecca A Nace; Yasuhiro Ikeda; Stephen J Russell
Journal:  Cancer Gene Ther       Date:  2022-02-10       Impact factor: 5.854

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.